The Future of Addiction Treatment Starts Here: GLP-1s Explained With Dr. Ken Spielvogel
1/20/202645 min
On this episode of We’re Out Of Time, host Richard Taite sits down with Dr. Ken Spielvogel, Senior Medical Officer at Carrera Treatment Wellness & Spa, to explore one of the most talked-about breakthroughs in addiction medicine: GLP-1 medications. Originally developed for diabetes and weight loss, emerging research now suggests GLP-1s may significantly reduce cravings, compulsive behavior, and relapse risk in people struggling with substance use disorders.
Dr. Spielvogel explains how GLP-1 medications are being used in addiction treatment, including why injectable options outperform oral medications when it comes to compliance and effectiveness. The conversation breaks do...
Clips
Showing 10 of 13Transcript preview
First 90 secondsKenneth Spielvogel· Guest0:00
You know, using these drugs without a s- to me, a supervised medical professional that's guiding you in terms of what you should be taking on top, how you should be exercising, how you should be m- you know, looking at metrics of fitness and longevity, then you're doing yourself a disservice, and so is the person that's just giving it to you.
Speaker 10:22
[upbeat music] If someone has a problem with substance use disorder, please call One Call Placement. That's 888-831-1581. And if we can't help you, we'll make a referral to someone who can. One Call Placement is affiliated with Carrera Treatment Wellness and Spa and One Method Treatment Centers.
Richard Taite· Host0:58
Today I'm with Dr. Kenneth Spielvogel, senior medical officer at Carrera Treatment Wellness and Spa, to talk about something a lot of people in addiction and mental health are watching closely: GLP-1 medications. These drugs were created for diabetes and weight loss, but early research shows they may also reduce cravings and relapse risk. With major new deals dramatically lowering their cost and expanding access, this